Raffa Wealth Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Other funds holding PTGX
Raffa Wealth Management's PTGX Position: Q3 2026 in Review
Raffa Wealth Management held its Protagonist Therapeutics (PTGX) position steady in Q3 2026 at 60 shares worth $8.45K. The position accounts for ﹤0.01% of the portfolio, ranked #463.
Raffa Wealth Management first reported a position in PTGX in Q2 2025 and has held it in 6 quarters since. 368 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.
- Raffa Wealth Management held 60 shares of Protagonist Therapeutics worth $8.45K as of Q3 2026.
- Raffa Wealth Management left its Protagonist Therapeutics share count unchanged in Q3 2026.
- Protagonist Therapeutics made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #463 holding.
- Raffa Wealth Management first reported a position in Protagonist Therapeutics in Q2 2025 and has held it in 6 quarters since.
- 368 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.
Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.